A2428
安西奈德
analytical standard
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C28H35FO7
化学文摘社编号:
分子量:
502.57
UNSPSC Code:
41116107
PubChem Substance ID:
EC Number:
256-915-2
MDL number:
grade
analytical standard
Quality Level
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
application(s)
forensics and toxicology
veterinary
format
neat
SMILES string
[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC6(CCCC6)O2)C(=O)COC(C)=O
InChI
1S/C28H35FO7/c1-16(30)34-15-22(33)28-23(35-26(36-28)9-4-5-10-26)13-20-19-7-6-17-12-18(31)8-11-24(17,2)27(19,29)21(32)14-25(20,28)3/h8,11-12,19-21,23,32H,4-7,9-10,13-15H2,1-3H3/t19-,20-,21-,23+,24-,25-,27-,28+/m0/s1
InChI key
ILKJAFIWWBXGDU-MOGDOJJUSA-N
Gene Information
human ... NR3C1(2908)
正在寻找类似产品? 访问 产品对比指南
General description
Amcinonide is a highly potent topical corticosteroid. It possesses pharmacological properties like anti-pruritic, anti-inflammatory and vasoconstrictive activity.
Application
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
存储类别
13 - Non Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
涉药品监管产品
此项目有
Contact dermatitis due to amcinonide.
E Sasaki et al.
Contact dermatitis, 18(1), 61-62 (1988-01-01)
Contact dermatitis from budesonide in a nasal spray without cross-reactivity to amcinonide.
P M Gamboa et al.
Contact dermatitis, 24(3), 227-228 (1991-03-01)
E M Koch et al.
Arzneimittel-Forschung, 36(10), 1540-1544 (1986-10-01)
The results of comparative studies with corticosteroid topicals on age-associated differences are presented. In each of the test series 10 to 14 subjects were included, either young adults aged 18-24 years or older adults aged 65-76 years. Tests on vasoconstriction
R C Cornell
Cutis, 31(5), 566-569 (1983-05-01)
Thirty-nine patients with psoriasis were treated either with amcinonide ointment 0.1 percent twice a day or with fluocinonide ointment 0.05 percent three times a day in a two-week, randomized, parallel-group, double-blind study. The severities of the skin lesions at baseline
Allergic contact dermatitis due to amcinonide.
R Hayakawa et al.
Contact dermatitis, 23(1), 49-50 (1990-07-01)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持